Novartis Gene Therapies is new name for gene therapy firm with growing RTP presence
Novartis Gene Therapies was formerly AveXis, whose gene therapy technology is based on the work of Jude Samulski, PhD, Professor of UNC Pharmacology and member of the UNC Gene Therapy Center.